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Adverse effects of intraperitoneal onlay mesh used for incisional hernia repair 
Complications liées à la pose de filets intrapéritonéaux lors de cures de hernie 
incisionnelle 
 
Introduction 
 
In the past 50 years, the use of prosthetic mesh in surgery has dramatically changed 
the management of primary, as well as incisional hernias. In contrast with suture 
repair, prosthetic mesh reparation permits a tension-free repair. The recurrence rate 
decreased from 43% to 24% after a first hernia and from 58% to 20% after a first 
incisional hernia with this method(1-3). Currently, there are a large number of different 
mesh brands and no consensus on the best material, nor the best mesh implantation 
technique to use(4).  
 
Two things play a role in mesh implantation: the technique used (open versus 
laparoscopic approach) and the localisation of the mesh (onlay, inlay, sublay).  
Currently, two mesh implantation techniques are most frequently used: the 
laparoscopic approach with intra-peritoneal onlay mesh (IPOM technique) and the 
open approach with insertion of a retro-muscular extra-peritoneal mesh (sublay) 
following Rives-Stoppa. Many studies compare IPOM and sublay techniques, but 
there is currently no consensus about the best technique to use from the point of 
view of morbidity and cost-benefit ratio.  
Many studies compare laparoscopic approach and open approach. A low recurrence 
rate is achieved by both techniques with no significant difference between them(5,6).  
The risk factors for recurrence are suture repair, infection, prostatism and previous 
history of abdominal surgery for aortic aneurysm. The size of the hernia, however, 
does not affect the rate of recurrence(1,7). Recurrence leads to discomfort and 
possible complications such as bowel incarceration resulting in ischemia, necrosis 
and perforation with high morbidity.  
Laparoscopy or laparotomy with mesh implantation may result in various 
complications such as infection, abscess, seroma formation, adhesion, fistula and 
nerve entrapment(5,8). Infections appear after colic perforation or with parietal 
necrosis. The average interval between operation and complications is about two 
years(9).  
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An intra-abdominal foreign body, as a mesh, induces an inflammatory response with 
activation of phagocytosis(10). This leads to the formation of adhesions between the 
mesh and the abdominal wall. Adhesions are part of the normal healing process and 
allows good incorporation of the mesh but it can also induce a weakening of the wall 
and an increased hernia recurrence rate. Adhesions of the mesh are also associated 
with bowel obstruction, bowel erosion, infertility, fistula and chronic pain and make 
reoperation technically difficult(3,5,10,11). Intra-abdominal adhesion is not specifically 
related to mesh placement, but is an inevitable consequence of surgery of any kind 
(laparotomy and laparoscopy) and appear in about 90% of all patients after 
abdominal surgery(11). 
 
Many studies show better results with laparoscopy compared to laparotomy in terms 
of length of hospital admission and number of complications such as infections and 
seroma, even if complications such as bowel injury tend to be more severe(5,12,13). 
Also, this technique requires more experience and more expensive equipment as 
laparotomy(5,12,13). In addition, there is a higher risk of bowel perforation with a 
laparoscopy. 
 
Currently the Department of the Visceral Surgery of CHUV uses a modified Rives-
Stoppa technique. It consists in an anatomical repair of the abdominal wall with 
placing of a retromuscular non-resorbable mesh. This mesh is placed behind the 
rectus muscle over the posterior fascia superior, or fascia transversalis inferior to the 
umbilicus(4,14). This technique encourages mesh incorporation because the mesh 
remains in direct contact with well vascularized muscle. This produces strengthening 
of the abdominal wall and an improved recovery with tension-free closure(7). This 
technique is associated with low rates of recurrence, infection, pain and seroma(4).  
 
Polypropylene mesh, for example Ultrapro® and Proceed®, are widely used(3,7). 
Some surgeons have observed that the structure and the chemical composition of 
the mesh both influences host tissue reaction equally(7). 
However owing to commercial pressure a large variety of non-resorbable and 
composite mesh types have appeared on the market, without sufficient transparent 
studies of complications using actual experience of patients. Indeed, most studies of 
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the effectiveness of mesh have been performed on experimental animal 
models(3,10,15).  
 
The type of mesh fixation may also play an important role in the development of 
complications. Mesh may be secured by spiral tackers, staples, or transfascial 
sutures(5). The cut edges of the mesh and spiral tack anchoring devices were 
associated directly with severe adhesions or even bowel perforation, especially 
where mesh migration had occurred. Moreover, the use of mesh fixation devices like 
tackers or transfascial sutures have sometimes resulted in severe chronic 
neuropathic pain due to nerve entrapment(4). The type of mesh fixation also 
determines the degree of tissue contraction (mesh shrinkage) and potentially affects 
the incidence of recurrent hernia(16,17). In a randomized clinical trial comparing suture 
versus tack mesh fixation, shows that transfacial anchoring sutures were associated 
with less mesh shrinkage after 6 months when compared with mesh fixation using 
tacks(16). 
 
Few studies have been carried out to examine the morbidity and long-term 
consequences of intraperitoneal prosthetic mesh placement.  
 
The purpose of this study is to illustrate the adverse effects of intraperitoneal 
onlay mesh used for incisional hernia repair encountered in patients treated at 
CHUV for complications after incisional hernia repair. The type of operation, type of 
mesh and duration between the first operation and appearance of complications were 
recorded.  
 
Materials and Methods 
 
Study design and protocol 
This report was prepared by permission of the Medical Director of the CHUV and  
by approval of the Vaud Cantonal Ethics Committee for Human Research. 
This work is an observational retrospective study. A PubMed search and a 
systematic review of literature were performed with the following key words: mesh; 
intra-peritoneal mesh; incisional hernia repair; laparotomy incisional hernia repair; 
laparoscopic incisional hernia repair; adhesions. 
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The medical records of 22 patients, who presented with pain, abdominal discomfort, 
ileus, fistula, abscess, seroma, mesh infection or recurrent incisional hernia after a 
laparoscopic or open repair with intra-abdominal mesh, were reviewed.   
 
Inclusion criteria 
All patients older than 18 years, who had between 2000 and 2011 complications 
such as pain, abdominal discomfort, ileus, fistula, abscess, seroma or infection, after 
incisional hernia with an intra-peritoneal mesh. Reoperations of complications or 
recurrences were performed in the Department of Visceral Surgery, CHUV, 
Lausanne, Switzerland. Complications found at surgery were recorded prospectively 
and photo documentation performed in every case during the procedure.  
 
Data record 
Sex, age, type of complication (pain, abdominal discomfort, ileus, fistula, abscess, 
seroma, infection), hernia recurrence, type of mesh used, type of mesh fixation, 
surgical approach (open approach versus laparoscopic approach), time from 
implantation in months, type of surgery (planned surgery versus emergency surgery), 
observation during the second operation (mesh migration, mesh adhesion, mesh 
shrinkage, nerve entrapment, seroma, abscess, fistula) and ASA score (American 
Society of Anesthesiology) were on recorded. 
 
Exclusion criteria:  
No complication found intraoperatively, no medical records concerning a first 
operation in another hospital or country, reoperation before year 2000. 
 
Data analysis 
All judgment criteria were analyzed from the medical records and were included in an 
Excel® table, version 14.1.3 and divided in Word® table 1 and table 2, version 14.1.3. 
Numeric variables are expressed as median.  
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Results 
 
Patient characteristics 
Patients # Sex Median 
age 
(ys) 
Associated 
diagnosis 
and 
symptoms 
Surgical 
approach: 
OA vs LS 
Time from 
implantation 
(months) 
Setting of 
surgery: 
PS vs ES 
Risk 
classification: 
ASA score 
1 M 41 Seroma OA 8 PS 2 
2 M 29 Rectal fistula OA 1 ES 2 
3 M 63 Pain, 
bloating 
LS 13 ES 3 
4 M 79 Pain LS 15 PS 2 
5 M 63 Discomfort, 
biliary colic 
LS 14 PS 2 
6 F 73 Fistula, 
abscess 
OA 147 ES 2 
7 M 60 Infection, 
dehiscence 
OA 1 ES 2 
8 F 73 Seroma OA 21-32 PS 3 
9 F 82 Seroma LS 17 PS 2 
10 F 73 Pain, acute 
cholecystitis 
LS 48 ES 2 
11 F 69 Discomfort OA 7 PS 3 
12 F 75 Pain OA 50 PS 2 
13 F 73 Pain, 
chronic 
cholecystitis 
LS 12 PS 2 
14 F 46 Ileus LS 1-12 ES 2 
15 F 30 Pain OA 29-41 PS 1 
16 M 43 Pain LS 123-134 ES 2 
17 M 24 Ileus OA 3 ES 4 
18 F 55 Pain OA 5 PS 3 
19 M 67 Ileus, 
abdominal 
pain 
OA 47 PS 2 
20 
 
F 
 
48 Abdominal 
pain, 
infection 
LS 
 
11 ES 3 
21 F 63 Infection, 
fistula 
OA 66 PS 2 
22 M 59 Discomfort, 
pain 
OA 31 PS 2 
 
Table 1: Patient characteristics. 
 
M: Male, F: Female, YS: years, OA: Open approach, LS: Laparoscopic approach, PS: Planned surgery, ES: Emergency 
surgery, ASA: American Society of Anesthesiologists 
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Twenty-two persons were reoperated for complications after incisional hernia repair 
with a prosthetic mesh. Ten were male and twelve female, with a median age of 58,6 
years (range 24-82).  
 
Presentation 
Associated diagnosis and symptoms resulting in reoperation are: 
• abdominal discomfort 
• abdominal pain 
• infection 
• seroma 
• fistula 
• ileus  
These were considered to be directly associated with intra-peritoneal mesh or with 
hernia recurrence. During an emergency procedure for unrelated pathology to a 
previous incisional hernia repair in one patient it was possible to visualize results 
associated with intraperitoneal mesh repair.  
 
Management 
Mesh placement was performed by a laparoscopic approach in nine patients and by 
open approach in thirteen others. The majority underwent elective operation for 
reoperation but nine underwent an emergency surgery. The setting of surgery 
(planned surgery versus emergency surgery) depended on the severity of symptoms.  
All patients had an ASA score between 1 and 4 and 15/22 (68%) had an ASA score 
of 2. 
Physical status ASA Score 
A normal healthy patient 1 
A patient with mild systemic disease 2 
A patient with severe systemic disease 3 
A patient with severe systemic disease that is a constant threat 
to life 
4 
A moribund patient who is not expected to survive without the 
operation 
5 
A declared brain-dead patient whose organs are being removed 
for donor purposes 
6 
Table 2 : ASA Physical Status Classification System from the American Society of Anesthesiology. 
 
These definitions appear in each annual edition of the ASA Relative Value Guide®. (http://www.asahq.org/clinical/physicalstatus.htm) 
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Outcome of patients following their previous cure of incisional hernia 
Patients # Hernia 
recurrence 
Mesh brand Mesh 
position 
Mesh fixation Mesh 
migration 
Mesh 
shrinkage 
Mesh 
adhesion 
Intraoperative 
findings: 
 S, F, A, NE, O 
1 yes Ultrapro® Onlay ProleneTM no yes yes S 
2 yes Mersilene®, 
Titanium Metals 
UK Ltd® 
Sublay ProleneTM yes no no F 
3 yes Parietex 
Composite® 
IPOM AbsobaTack TM no no yes NE 
4 yes Proceed® IPOM ProTackTM no no yes O 
5 yes Proceed® IPOM EasyTackTM yes no yes O 
6 no Mersilene® IPOM ProleneTM no no yes F, A 
7 yes Proceed®, 
DynaMesh® 
IPOM ProleneTM 
 
no yes yes O 
8 yes DynaMesh® Sublay ProleneTM no yes yes S 
9 yes Proceed® Onlay ProTackTM yes yes yes S 
10 no Ultrapro® IPOM ProTackTM 
 
no no yes O 
11 yes Parietex 
Composite® 
IPOM ProTackTM no no yes O 
12 no Ultrapro®, 
Parietex 
Composite® 
IPOM ProleneTM no no yes O 
13 no Proceed® IPOM ProTackTM 
 
no no yes NE 
14 no Parietex 
Composite® 
IPOM ProTackTM no no yes O 
15 no Ultrapro® Sublay ProTackTM no no yes NE 
16 no Parietex 
Composite® 
IPOM ProleneTM no no yes NE 
17 yes Gore® 
DualMesh® 
IPOM ProleneTM no no yes O 
18 yes Permacol® IPOM ProleneTM no yes yes O 
19 yes Proceed® IPOM ProTackTM 
 
yes no yes O 
20 
 
yes Parietex 
Composite® 
IPOM AbsorbaTackTM no no yes F, A 
21 yes Parietex 
Composite®, 
Mersilene® 
IPOM ProleneTM no no yes F, A 
22 yes Permacol® IPOM ProleneTM yes yes yes O 
 
Table 3: Patients after cure of incisional hernia. 
 
S: Seroma, F: Fistula, A: Abscess, NE: Nerve entrapment, O: Other 
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Mesh brand 
Eight different mesh brands 
were found in patients in this 
study. The most frequently 
found was Parietex 
Composite®, followed by 
Proceed®. Titanium Metals UK 
Ltd® and Gore® DualMesh® 
were each found in one patient.  
 
 
 
 
 
 
 
Figure 1 : Distribution of the different mesh brands. 
 
 
Complications 
In our sample of 22 patients, 15 (68%) presented with hernia recurrence. Hernia 
recurrence was seen with every type of mesh brand. Mesh adhesions is present in 
21/22 patients (96%). No complication as bowel strangulation, ischemia or necrosis 
was observed. 
 
Figure 2: Type of complication by mesh brand. 
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The median time from initial mesh implantation to reoperation was 34.2 months 
(range 1-147). Table number 4 summaries the percentage distribution of recurrent 
hernias and the median time interval between intraperitoneal mesh placement and 
reoperation for complication. Ultrapro® mesh was associated with the lowest hernia 
recurrence rate. Hernia recurrences always appeared with Titanium Metals UK Ltd®, 
DynaMesh®, Gore® DualMesh® and Permacol® meshes. A link between brand of 
mesh and frequency of hernia recurrence cannot, however, be made in this small 
study. Time from implantation was a larger time interval between mesh implantation 
and re-intervention for complications with Mersilene®, Parietex Composite® and 
Ultrapro® mesh.  
 
Mesh brand Mesh composition Hernia recurrence Time from implantation 
(Months) 
Ultrapro® polypropylene & 
poliglecaprone 25 
1/4 (25%) 35,2 
Parietex Composite® polyester & collagen 4/7 (57%) 46,3 
Proceed® oxidized regenerated 
cellulose & Prolene 
5/6 (83,3%) 17,7 
Mersilene® 
 
Titanium Metals UK Ltd® 
polyester 
 
polypropylene & 
titanium 
2/3 (67%) 
 
1/1 (100%) 
71,3 
 
1 
DynaMesh® polyvinylidene 
fluoride & 
polypropylene 
2/2 (100%) 18 
Gore® DualMesh® ePTFE 1/1 (100%) 3 
Permacol® porcin collagen 2/2 (100%) 18 
 
Table 4 : Percentage of recurrent hernias and time interval between intraperitoneal mesh placement 
Prolene = polypropylene & polydioxanone polymer 
polytetrafluoroethylene (PTFE) 
 
Various consequences were associated with intraperitoneal mesh placement like 
mesh migration, mesh shrinkage, mesh adhesion, fistula, abscess, seroma and 
nerve entrapment. (Table 3)   
Mesh adhesion was most frequently seen, it was present in 21/22 (96%) of patients 
in this study. Of note, any abdominal surgical intervention was associated with the 
formation of adhesion and particularly when reoperation for complication was 
necessary. The only mesh that was not associated with adhesions is the Titanium 
Metals UK Ltd®. However, this mesh was found in only one person in this study 
(4,6%).  
Abscesses were observed with Mersilene® and Parietex Composite®. Fistulas were 
observed with Mersilene®, Parietex Composite® and Titanium Metals UK Ltd®. 
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Seroma was observed with Ultrapro®, Proceed® and DynaMesh®. Nerve entrapment 
was observed with Ultrapro®, Parietex Composite® and Proceed®. Nerve entrapment 
was associeted with chronic pain and is really difficult to objectified during surgical 
intervention. Mesh migration was present in 5/22 of our patients (23%). Mesh 
shrinkage was present in 6/22 of patients (27%) even if the mesh was fixed with a 
non resorbable thread (Prolene®) in 5/6 cases (83%).  
 
Illustration 
 
Figure 3: mesh adhesions. 
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Figure 4: severe mesh adhesions and presence of 2 resorbable spiral fixation (tacks).  
 
 
Figure 5: mesh adhesions and firm adhesions to small bowel. 
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Figure 6: adhesions to small bowel and fistula formation. Adhesions are maximal at anchoring sites. 
 
 
 
Figure 7: seroma formation above the mesh with a thickened chronic inflammatory shell-like formation. 
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Figure 8: severe adhesions with the mesh embedded into the small bowel, fistula formation and hernia recurrence. 
 
Discussion 
 
This retrospective study shows that placement of an intraperitoneal mesh was 
associated with complications which are numerous, various, frequent and severe.  
The most common was mesh adhesion, present in 21/22 (96%) of patients 
reoperated in this study. The problem of adhesion and related effects is a high 
morbidity with increase of medical costs(11). The second common complication was 
hernia recurrence, present in 15/22 (68%) of patients. This complication strongly 
correlates with the presence of adhesions except with the Ultrapro® mesh brand. 
Hernia recurrence is a major problem after a primary incisional hernia repair. This 
carries a high morbidity and high risk of resulting severe complications such as bowel 
incarceration leading to ischemia, necrosis and perforation. Mesh shrinkage was 
present in 6/22 (27%). Mesh migration was present in 5/22 (23%). This problem can 
lead to further complications such as intestinal perforation and more severe 
adhesions(4). There was less migration if the incorporation of the mesh is 
considerable(3) . Abscess and seroma were each observed in 3/22 (14%), fistula and 
nerve entrapment were each observed in 4/22 (18%).  
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Limitations of the study  
This work is an observational study with a small sample of individuals. Only patients 
with objectifiable complications during surgical reoperation were recruited, giving a 
selection bias. Thus no assumption concerning the frequency of complications, 
symptomatic or asymptomatic, associated with intraperitoneal mesh, can be made in 
this study. 
Data were recorded in medical records written by different persons and some 
information have been may forgotten or interpreted differently. However, operations 
and data collections were always achieved by the same surgical team.    
 
Conclusion 
The majority of articles deal with complications induced by intraperitoneal prosthetic 
mesh, but the effectiveness of mesh has been studied mostly on experimental 
models. Actually and as shown in the present study, intraperitoneal mesh placement 
was associated with severe complications witch may potentially be life threatening. 
Therefore the Department of the Visceral Surgery of CHUV avoids the IPOM 
technique.  
Randomized controlled trials comparing effectiveness of different meshes, placed 
intraperitoneally or beneath the muscle would be the best way to answer these 
questions but may be difficult or impossible to conduct. Above all, the follow up of 
patients for such a study would generate terrible costs.  
The most important thing to remember is to be extremely careful with the use of 
prosthetic mesh and to inform patients about the risks of adhesions and other 
complications with the use of onlay mesh. 
In our opinion, intraperitoneal mesh placement should only be reserved in 
exceptional situations, when the modified Rives-Stoppa could not be achieved and 
when tissues covering the mesh are insufficient. 
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